SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-21-021779
Filing Date
2021-06-03
Accepted
2021-06-03 16:19:01
Documents
1
Period of Report
2021-05-24

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 8337
  Complete submission text file 0000899243-21-021779.txt   9698
Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 857-204-4583
iTeos Therapeutics, Inc. (Issuer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ITEOS THERAPEUTICS, INC. 139 MAIN STREET CAMBRIDGE MA 02142
Business Address
McGrath Yvonne (Reporting) CIK: 0001816213 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39401 | Film No.: 21992729